Italian Lung Cancer Observational Study

LUCENT is an observational study focused on malignant pulmonary and tracheo-bronchial disease. It involves a large proportion of reference Italian thoracic surgery centers. The relevance of the study is related to the epidemiology of lung cancer in the world - also known as "Big Killer" - and the high mortality rates both in males and females. The aim of his prospective study is to collect a large bulk of postoperative patients' outcome data and to produce up-to-date descriptive statistics of patients undergoing surgery for lung cancer. These results will be pivotal to compare the clinical results of all the relevant specialities involved in the care of lung cancer such as medical oncologists and radiation oncologists.

NCT Number	NCT05851755
Lead Sponsor	The Mediterranean Institute for Transplantation and Advanced Specialized Therapies Collaborators: S. Andrea Hospital, Azienda Policlinico Umberto I, Azienda Ospedaliero, Universitaria Pisana, Università degli Studi dell'Aquila, University of Milan, Azienda Ospedaliera di Perugia, Monaldi Hospital, Azienda Ospedaliera di Bolzano, AUSL Romagna Rimini, European Institute of Oncology, Università degli Studi di Ferrara, Azienda Socio Sanitaria Territoriale di Mantova
Conditions	Lung Cancer
Enrollment	1,000 participants
Start Date	2023-04-01
Primary Completion	2028-03-31 (estimated)
Study Completion	2028-03-31 (estimated)
Updated on ClinicalTrials.gov	2023-05-10